导师简介

一、个人信息：

王新，博士，副研究员，硕士生导师，海南D类高层次人才。

二、教育经历：

2012年9月-2016年7月 沈阳药科大学   本科/药物制剂

2016年9月-2021年8月 沈阳药科大学   硕博连读/药剂学

2021年9月-2024年12月 南京鼓楼医院   博士后/药学

三、主要工作经历：

2025.02 - 至今 海南医科大学

四、主要学术成果

[1] Bowen Zhang^#, Xin Wang^#, Yi Zheng, Minglong Huang, Qing Wang, Jin Sun, Zhonggui He, Lingxiao Li, Bingjun Sun. Emerging selenium-containing nano-systems for cancer therapy. Coordination Chemistry Reviews. 2026, 548, 217159.

[2] Lurong Zhang^#, Xin Wang^#, Xuan Li, Minglong Huang, Bowen Zhang, Shengyao Xu, Jialin Xing, Yafan Xiao, Yi Zheng, Zhenzhen Zhao, Jin Sun, Zhonggui He, Lingxiao Li, Bingjun Sun. Fine-tuning PEGylation: Leveraging the self-assembly stability and targeting efficiency of biotinylated-paclitaxel prodrug nanoassemblies. Chinese Chemical Letters. 2025, 111694.

[3] Minglong Huang^#, Xin Wang^#, Jialin Xing, Bowen Zhang, Lurong Zhang, Yaqiao Li, Hongying Xiao, Qing Wang, Jun Yuan, Yafan Xiao, Zhenzhen Zhao, Zhonggui He, Lingxiao Li, Bingjun Sun. A fatty acid modification strategy to improve the binding affinity of Epirubicin to human serum albumin for efficient cancer therapy. Chemical Engineering Journal. 2025, 519, 165724.

[4] Lingxiao Li^#, Xin Wang^#, Yafan Xiao, Minglong Huang, Shiyi Zuo, Yingjie Zhao,

Xiaoyuan Fan, Qi Lu, Xin Li, Yuki Takahashi, Zhonggui He, Yoshinobu Takakura, Bingjun Sun, and Jin Sun. A "Glue" Strategy to Engineer Cancer Cell Membrane-Camouflaged Prodrug Nanoassemblies for Efficient Targeted Chemotherapy. Small. 2025, 21(34):e2503057. 

[5]Xin Wang, Tian Liu, Yuetong Huang, Fudan Dong, Lingxiao Li, Jiaxuan Song, Shiyi Zuo, Zhengyang Zhu, Ken-Ichiro Kamei, Zhonggui He, Bingjun Sun, Jin Sun. Critical roles of linker length in determining the chemical and self-assembly stability of SN38 homodimeric nanoprodrugs. Nanoscale Horizons. 2023, 8(2):235-244.

[6]Xin Wang,  Lingxiao Li, Danping Wang, Shiyi Zuo, Tian Liu, Fudan Dong, Xuanbo Zhang, Zhonggui He, Bingjun Sun, Jin Sun. Minor change in the length of carbon chain has a great influence on the antitumor effect of paclitaxel-fatty alcohol prodrug nanoassemblies: Small roles, big impacts. Nano Research. 2022, 15, 3367-3375.

[7] Xin Wang, Bin Yang, Lingxiao Li, Tian Liu, Shiyi Zuo, Dongxu Chi, Zhonggui He, Bingjun Sun, Jin Sun. Probing the fluorination effect on the self-assembly characteristics, in vivo fate and antitumor efficacy of paclitaxel prodrug nanoassemblies. Theranostics, 2021, 11(16):7896-7910.

[8] 国家自然自科学基金，靶向激活 MRI纳米探针增强动脉粥样硬化易损斑块的成像对比度与治疗效果研究（82302276），2024.01 - 2026.12，在研，主持。

[9] 中国博士后科学基金，靶向放大T1加权磁共振成像探针用于早期动脉粥样硬化易损斑块的诊疗一体化研究（2022M721580），2023.01 - 2025.12，结题，主持。

[10] 江苏省自然科学基金，靶向炎性巨噬细胞的诊疗一体化纳米探针在动脉粥样硬化的应用研究（BK20220181），2022.07 - 2025.06，在研, 主持。

五、学术组织兼职：无。

六、获得奖励：

[1] 王新(4/5); Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading; high self-assembly stability; and high tumor selectivity, 沈阳市自然科学学术成果二等奖，2023。

七、联系方式：

wang_xin@muhn.edu.cn